Author: Recio, Raúl; Lalueza, Antonio; Moral, Noelia; Pascual, Consuelo; Muñoz, Marina; Camacho, Javier; Caso, José MarÃa; Folgueira, Lola
                    Title: Lack of clinical significance for molecular detection of respiratory viruses in bronchoalveolar lavage samples.  Cord-id: jqjxom8r  Document date: 2021_2_2
                    ID: jqjxom8r
                    
                    Snippet: The clinical significance of molecular detection of respiratory viruses in bronchoalveolar lavage (BAL) samples is poorly defined. We performed an observational retrospective study including all patients who underwent a BAL procedure in our institution, regardless of the reason for bronchoscopy, from January 2015-December 2018. Respiratory viruses were detected by real-time polymerase chain reaction with a commercial multiplex panel, and a cell culture was performed to detect cytomegalovirus and
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: The clinical significance of molecular detection of respiratory viruses in bronchoalveolar lavage (BAL) samples is poorly defined. We performed an observational retrospective study including all patients who underwent a BAL procedure in our institution, regardless of the reason for bronchoscopy, from January 2015-December 2018. Respiratory viruses were detected by real-time polymerase chain reaction with a commercial multiplex panel, and a cell culture was performed to detect cytomegalovirus and herpes simplex virus. Positive results were correlated with clinical symptoms and patients' characteristics. Of 540 BAL samples analysed, 113 (20.9%) were positive for any respiratory virus. Viral detection was significantly associated with respiratory symptoms (83.2% vs 68.9%, P=.004) and radiological infiltrates (67.3% vs 52.2%, P=.006). The most frequent viruses detected were rhinovirus (42/113, 37.2%), influenza virus (20/113, 17.7%) and parainfluenza virus (PIV) (16/113, 14.2%). Respiratory pathogens codetections were found in 51/113 (45.1%) BAL samples, including more than one virus (16/51, 31.4%), fungi (8/51, 15.7%, and bacteria (9/51, 17.6%). Viral detection was significantly higher in immunocompromised patients (26.5% vs 16.9%; P=.022). PIV and human metapneumovirus were mostly observed in lung (50.0%, 8/16) and haemopoietic transplant recipients (25%, 2/8), respectively, with clinical repercussions. Our data underline that molecular diagnosis allows identification of viral agents as the aetiology of respiratory infections; however, the high frequency of co-detections hinders identification of the agent responsible for the current respiratory symptomatology. Immunocompromised patients are the target population in whom to investigate the presence of respiratory viruses in their BAL samples. This article is protected by copyright. All rights reserved.
 
  Search related documents: 
                                Co phrase  search for related documents- Try single phrases listed below for: 1
 
                                Co phrase  search for related documents, hyperlinks ordered by date